433 related articles for article (PubMed ID: 36471747)
1. Rett Syndrome and
Collins BE; Neul JL
Neuropsychiatr Dis Treat; 2022; 18():2813-2835. PubMed ID: 36471747
[TBL] [Abstract][Full Text] [Related]
2. Identification of molecular signatures and pathways involved in Rett syndrome using a multi-omics approach.
Pascual-Alonso A; Xiol C; Smirnov D; Kopajtich R; Prokisch H; Armstrong J
Hum Genomics; 2023 Sep; 17(1):85. PubMed ID: 37710353
[TBL] [Abstract][Full Text] [Related]
3. Rett syndrome: the complex nature of a monogenic disease.
Renieri A; Meloni I; Longo I; Ariani F; Mari F; Pescucci C; Cambi F
J Mol Med (Berl); 2003 Jun; 81(6):346-54. PubMed ID: 12750821
[TBL] [Abstract][Full Text] [Related]
4. Two new Rett syndrome families and review of the literature: expanding the knowledge of MECP2 frameshift mutations.
Ravn K; Roende G; Duno M; Fuglsang K; Eiklid KL; Tümer Z; Nielsen JB; Skjeldal OH
Orphanet J Rare Dis; 2011 Aug; 6():58. PubMed ID: 21878110
[TBL] [Abstract][Full Text] [Related]
5. Advanced genetic therapies for the treatment of Rett syndrome: state of the art and future perspectives.
Palmieri M; Pozzer D; Landsberger N
Front Neurosci; 2023; 17():1172805. PubMed ID: 37304036
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of genetic MECP2 supplementation in the R294X mouse model of Rett syndrome.
Collins BE; Merritt JK; Erickson KR; Neul JL
Genes Brain Behav; 2022 Jan; 21(1):e12739. PubMed ID: 33942492
[TBL] [Abstract][Full Text] [Related]
7. MECP2 mutations and clinical correlations in Greek children with Rett syndrome and associated neurodevelopmental disorders.
Psoni S; Sofocleous C; Traeger-Synodinos J; Kitsiou-Tzeli S; Kanavakis E; Fryssira-Kanioura H
Brain Dev; 2012 Jun; 34(6):487-95. PubMed ID: 21982064
[TBL] [Abstract][Full Text] [Related]
8. Role of DNA Methyl-CpG-Binding Protein MeCP2 in Rett Syndrome Pathobiology and Mechanism of Disease.
Pejhan S; Rastegar M
Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33429932
[TBL] [Abstract][Full Text] [Related]
9. Rett syndrome: methyl-CpG-binding protein 2 mutations and phenotype-genotype correlations.
Amir RE; Zoghbi HY
Am J Med Genet; 2000; 97(2):147-52. PubMed ID: 11180222
[TBL] [Abstract][Full Text] [Related]
10.
Pascual-Alonso A; Martínez-Monseny AF; Xiol C; Armstrong J
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502518
[TBL] [Abstract][Full Text] [Related]
11. Rett syndrome and MeCP2.
Liyanage VR; Rastegar M
Neuromolecular Med; 2014 Jun; 16(2):231-64. PubMed ID: 24615633
[TBL] [Abstract][Full Text] [Related]
12. Sensory experiences questionnaire unravels differences in sensory profiles between MECP2-related disorders.
Suter B; Pehlivan D; Ak M; Harris HK; Lyons-Warren AM
Autism Res; 2024 Apr; 17(4):775-784. PubMed ID: 38433353
[TBL] [Abstract][Full Text] [Related]
13. Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome.
Filosa S; Pecorelli A; D'Esposito M; Valacchi G; Hajek J
Free Radic Biol Med; 2015 Nov; 88(Pt A):81-90. PubMed ID: 25960047
[TBL] [Abstract][Full Text] [Related]
14. MECP2 mutations in Czech patients with Rett syndrome and Rett-like phenotypes: novel mutations, genotype-phenotype correlations and validation of high-resolution melting analysis for mutation scanning.
Zahorakova D; Lelkova P; Gregor V; Magner M; Zeman J; Martasek P
J Hum Genet; 2016 Jul; 61(7):617-25. PubMed ID: 26984561
[TBL] [Abstract][Full Text] [Related]
15. MECP2 Duplication Syndrome: Evidence of Enhanced Oxidative Stress. A Comparison with Rett Syndrome.
Signorini C; De Felice C; Leoncini S; Møller RS; Zollo G; Buoni S; Cortelazzo A; Guerranti R; Durand T; Ciccoli L; D'Esposito M; Ravn K; Hayek J
PLoS One; 2016; 11(3):e0150101. PubMed ID: 26930212
[TBL] [Abstract][Full Text] [Related]
16. MeCP2 mutations in children with and without the phenotype of Rett syndrome.
Hoffbuhr K; Devaney JM; LaFleur B; Sirianni N; Scacheri C; Giron J; Schuette J; Innis J; Marino M; Philippart M; Narayanan V; Umansky R; Kronn D; Hoffman EP; Naidu S
Neurology; 2001 Jun; 56(11):1486-95. PubMed ID: 11402105
[TBL] [Abstract][Full Text] [Related]
17. Rett-causing mutations reveal two domains critical for MeCP2 function and for toxicity in MECP2 duplication syndrome mice.
Heckman LD; Chahrour MH; Zoghbi HY
Elife; 2014 Jun; 3():. PubMed ID: 24970834
[TBL] [Abstract][Full Text] [Related]
18. Unraveling Molecular Pathways Altered in MeCP2-Related Syndromes, in the Search for New Potential Avenues for Therapy.
Castells AA; Balada R; Tristán-Noguero A; O'Callaghan M; Cortès-Saladelafont E; Pascual-Alonso A; Garcia-Cazorla À; Armstrong J; Alcántara S
Biomedicines; 2021 Feb; 9(2):. PubMed ID: 33546327
[TBL] [Abstract][Full Text] [Related]
19. Genetic and clinical variations in a Norwegian sample diagnosed with Rett syndrome.
Henriksen MW; Breck H; Sejersted Y; Diseth T; von Tetzchner S; Paus B; Skjeldal OH
Brain Dev; 2020 Aug; 42(7):484-495. PubMed ID: 32336485
[TBL] [Abstract][Full Text] [Related]
20. Rett Syndrome and Fragile X Syndrome: Different Etiology With Common Molecular Dysfunctions.
Bach S; Shovlin S; Moriarty M; Bardoni B; Tropea D
Front Cell Neurosci; 2021; 15():764761. PubMed ID: 34867203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
